(NaturalNews) AstraZeneca is investing $50 billion in U.S. operations by 2030, including its largest-ever manufacturing plant in Virginia specializing in respir…
AstraZeneca’s $50B U.S. expansion signals shift in pharma manufacturing amid tariff threat

Estimated read time
1 min read